Millennium Management
WST icon

Millennium Management’s West Pharmaceutical WST Stock Holding History

Millennium Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,000
Closed -$525K – 6523
2025
Q3 		$525K Sell
2,000
-2,000
-50% -$486K ﹤0.01% 5035
2025
Q2 		$875K Sell
4,000
-4,400
-52% -$941K ﹤0.01% 4509
2025
Q1 		$1.88M Sell
8,400
-2,700
-24% -$744K ﹤0.01% 3838
2024
Q4 		$3.64M Buy
11,100
+5,000
+82% +$1.57M ﹤0.01% 3124
2024
Q3 		$1.83M Sell
6,100
-54,900
-90% -$16.8M ﹤0.01% 3777
2024
Q2 		$20.1M Buy
61,000
+55,900
+1,096% +$19.8M 0.01% 1497
2024
Q1 		$2.02M Sell
5,100
-9,900
-66% -$3.66M ﹤0.01% 3732
2023
Q4 		$5.28M Buy
+15,000
New +$5.31M ﹤0.01% 2743
2022
Q4 		– Sell
-5,000
Closed -$1.23M – 7116
2022
Q3 		$1.23M Sell
5,000
-55,000
-92% -$16.8M ﹤0.01% 4157
2022
Q2 		$18.1M Buy
60,000
+10,000
+20% +$3.25M 0.01% 1414
2022
Q1 		$20.5M Buy
50,000
+19,000
+61% +$7.44M 0.01% 1368
2021
Q4 		$14.5M Buy
31,000
+16,000
+107% +$6.89M 0.01% 1748
2021
Q3 		$6.37M Buy
+15,000
New +$6.32M ﹤0.01% 2590
2019
Q2 		– Sell
-4,000
Closed -$441K – 4518
2019
Q1 		$441K Buy
+4,000
New +$416K ﹤0.01% 3350

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management's WST Position: Q1 2026 in Review

Millennium Management reduced its West Pharmaceutical (WST) stake by 88% in Q1 2026, selling an estimated $24M and leaving 13,775 shares worth $3.45M. The position accounts for ﹤0.01% of the portfolio, ranked #3339.

Millennium Management first reported a position in WST in Q4 2013 and has held it in 45 quarters since. The position peaked at $204M in Q1 2024. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Millennium Management held 13,775 shares of West Pharmaceutical worth $3.45M as of Q1 2026.
  • Millennium Management sold 96,618 West Pharmaceutical shares in Q1 2026, an estimated $24M.
  • West Pharmaceutical made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3339 holding.
  • Millennium Management first reported a position in West Pharmaceutical in Q4 2013 and has held it in 45 quarters since.
  • Millennium Management's West Pharmaceutical position peaked at $204M in Q1 2024.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.